Castration Resistant Prostatic Neoplasms Active Not Recruiting Phase 1 Trials for Enzalutamide (DB08899)

Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant

IndicationStatusPhase
DBCOND0129140 (Castration Resistant Prostatic Neoplasms)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02204072BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)Treatment